Venetoclax: evidence to date and clinical potential

The emergence of targeted therapy for patients with hematological diseases has permanently altered the therapeutic landscape. Immunochemotherapy regimes are now more and more being replaced by targeted therapies due to superior efficacy and better safety profiles. However, evolution and selection of...

Full description

Saved in:
Bibliographic Details
Published inDrugs in Context Vol. 8; pp. 212574 - 13
Main Authors Juárez-Salcedo, Luis Miguel, Desai, Viraj, Dalia, Samir
Format Journal Article
LanguageEnglish
Published BioExcel Publishing Ltd 09.10.2019
Subjects
Online AccessGet full text

Cover

Loading…